Market Overview:
The global dyspareunia treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of dyspareunia, rising awareness about available treatments, and growing demand for minimally invasive procedures. The global dyspareunia treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into medication and services. The medication segment is further sub-segmented into oral medications and topical medications. The services segment includes surgical procedures and other treatments such as physical therapy or counseling sessions. On the basis of application, the market is divided into hospitals and clinics. Geographically, it has been analyzed across North America (U S Canada), Latin America (Mexico Brazil), Europe (Germany France Italy Spain United Kingdom Rest Of Europe), Asia Pacific (Japan China India Australia South Korea Rest Of Asia Pacific) And Middle East & Africa(GCC Countries Turkey Nigeria South Africa Rest Of MEA).
Product Definition:
Dyspareunia Treatment is the medical treatment of dyspareunia, a condition in which a person experiences pain during sexual intercourse. The goal of Dyspareunia Treatment is to relieve pain and improve sexual function.
Medication:
Medication for dyspareunia is a drug or medication which is used to treat the pain experienced in the vaginal area. It works by increasing blood flow to this region and other parts of the body. Medications can be categorized into two types: OTC medications such as aloe vera, lube, etc., and prescription medications such as nitrates, antidepressants, etc.
Services:
Services and it's usage in dyspareunia treatment market is a new emerging area of interest for healthcare professionals. The lack of knowledge regarding the cause or nature of the problem, particularly in women, has led to a wide range of treatments being offered. This includes pharmaceutical products such as vaginal creams and tablets prescribed by doctors as well as alternative therapies such as reflexology and acupuncture which are not only unpropitious but also have no scientific evidence to support their claims.
Application Insights:
Based on application, the global dyspareunia treatment market is segmented into hospitals, clinics and other medical facilities, and private practices. Hospitals held the largest share in 2017 owing to availability of advanced healthcare infrastructure at prime locations along with highly skilled personnel. Moreover, rising prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer, diabetes mellitus among others will drive demand for hospital based services which in turn will fuel market growth over the forecast period.
Clinics and other medical facilities are anticipated to witness lucrative growth over the forecast period due to increasing awareness about available treatments for different disorders coupled with growing emphasis on sexual health by physicians at these facilities. Increasing number of sexologists or therapists employed by these centers will also boost demand for treatment procedures during future years. Furthermore, rising adoption of minimally invasive surgeries performed at these centers may further increase revenue generation capabilities during future years.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing cases of sexual dysfunction and rising awareness about available treatment options. In addition, presence of key pharmaceutical companies that are engaged in dyspareunia drug development will help North America maintain its dominance over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to growing medical tourism, improving healthcare infrastructure and rising disposable income levels among individuals from developing economies such as India and China. Moreover, availability of effective treatment methods at affordable costs for patients from these countries will boost regional growth further on account of rapid economic development witnessed by Asia Pacific countries over past few years which has resulted into increased purchasing power with consumers thus enabling them choose quality healthcare services more freely than ever before resulting into higher demand for various treatments including those pertaining health conditions associated with sexual dysfunction such as Dyspareunia (painful sex).
Growth Factors:
- Increasing prevalence of dyspareunia
- Growing awareness about dyspareunia and its treatment options
- Rising demand for minimally invasive procedures for dyspareunia treatment
- Technological advancements in the field of dyspareunia treatment
- Growing number of surgical centers offering dyspareunia treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Dyspareunia Treatment Market Research Report
By Type
Medication, Services
By Application
Hospitals, Clinics
By Companies
TherapeuticsMD Inc, AbbVie Inc., Laboratories VIVACY, GTO Pharmaceutical LLC, Hormos Medical Oy (QuatRx Pharmaceuticals), EndoCeutics Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Dyspareunia Treatment Market Report Segments:
The global Dyspareunia Treatment market is segmented on the basis of:
Types
Medication, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- TherapeuticsMD Inc
- AbbVie Inc.
- Laboratories VIVACY
- GTO Pharmaceutical LLC
- Hormos Medical Oy (QuatRx Pharmaceuticals)
- EndoCeutics Inc
Highlights of The Dyspareunia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medication
- Services
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dyspareunia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best dyspareunia treatment will vary depending on the individual's symptoms and situation. However, some possible treatments include:nn1. Treating underlying causes of dyspareunia such as pain relief medication or surgery for conditions like vaginismus.n2. Using topical treatments such as creams or gels to relieve discomfort and inflammation.n3. Participating in sex therapy which can help improve communication and intimacy during sexual activity.
Some of the major players in the dyspareunia treatment market are TherapeuticsMD Inc, AbbVie Inc., Laboratories VIVACY, GTO Pharmaceutical LLC, Hormos Medical Oy (QuatRx Pharmaceuticals), EndoCeutics Inc.
The dyspareunia treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dyspareunia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dyspareunia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dyspareunia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dyspareunia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dyspareunia Treatment Market Size & Forecast, 2018-2028
4.5.1 Dyspareunia Treatment Market Size and Y-o-Y Growth
4.5.2 Dyspareunia Treatment Market Absolute $ Opportunity
Chapter 5 Global Dyspareunia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dyspareunia Treatment Market Size Forecast by Type
5.2.1 Medication
5.2.2 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dyspareunia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dyspareunia Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dyspareunia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dyspareunia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dyspareunia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Dyspareunia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dyspareunia Treatment Market Size Forecast by Type
9.6.1 Medication
9.6.2 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dyspareunia Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dyspareunia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Dyspareunia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dyspareunia Treatment Market Size Forecast by Type
10.6.1 Medication
10.6.2 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dyspareunia Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dyspareunia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dyspareunia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dyspareunia Treatment Market Size Forecast by Type
11.6.1 Medication
11.6.2 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dyspareunia Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dyspareunia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Dyspareunia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dyspareunia Treatment Market Size Forecast by Type
12.6.1 Medication
12.6.2 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dyspareunia Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dyspareunia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dyspareunia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dyspareunia Treatment Market Size Forecast by Type
13.6.1 Medication
13.6.2 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dyspareunia Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dyspareunia Treatment Market: Competitive Dashboard
14.2 Global Dyspareunia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 TherapeuticsMD Inc
14.3.2 AbbVie Inc.
14.3.3 Laboratories VIVACY
14.3.4 GTO Pharmaceutical LLC
14.3.5 Hormos Medical Oy (QuatRx Pharmaceuticals)
14.3.6 EndoCeutics Inc
